Altered GLP-1 concentrations could also potentially cause the low glucagon concentrations in VLCAD subjects, since GLP-1 receptor activation on the pancreatic α-cell inhibits glucagon secretion [30]. This evidence concerns the gene GCG and very long chain acyl-CoA dehydrogenase deficiency.